C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 335/20 (2006.01) A61K 31/17 (2006.01) A61P 31/22 (2006.01) C07C 275/42 (2006.01) C07C 335/22 (2006.01) C07D 217/26 (2006.01) C07D 295/088 (2006.01) C07D 307/81 (2006.01) C07D 307/85 (2006.01)
Patent
CA 2351403
Compounds of formula (I), wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, - SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R12 may be taken together to form aryl of 5 to 7 carbon atoms; provided that at least one of R9-12 is not hydrogen; W is O, NR6, or is absent; Y is -(CO)- or - (CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms, -CN, -CO2R6, COR6, - CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), - N(R7R8) or phenyl; G is aryl or fused bicyclic heteroaryl; and X is a bond, - NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6, in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpes virus.
La présente invention concerne des composés représentés par la formule générale (I). Dans cette formule, R¿1?-R¿5? sont indépendamment hydrogène, C¿1?-C¿6? alkyle, C¿2?-C¿6? alcényle, C¿2?-C¿6? alkynyle, C¿1?-C¿6? perhaloalkyle, C¿3?-C¿10? cycloalkyle, C¿3?-C¿10? hétérocycloalkyle, aryle, hétéroaryle, halogène, -CN, -NO¿2?, -CO¿2?R¿6?, -COR¿6?, -OR¿6?, -SR¿6?, -SOR¿6?, -SO¿2?R¿6?, -CONR¿7?R¿8?, -NR¿6?N(R¿7?R¿8?), -N(R¿7?R¿8?) ou W-Y-(CH¿2?)¿n?-Z sous la réserve que l'un au moins des R¿1?-R¿5? ne soit pas hydrogène; ou que R¿2? pris avec R¿3? ou R¿3? pris avec R¿4? forment un hétérocycloalkyle de 3 à 7 segments ou un hétéroaryle de 3 à 7 segments; R¿6? et R¿7? sont indépendamment hydrogène, C¿1?-C¿6? alkyle, C¿1?-C¿6? perhaloalkyle, ou aryle; R¿8? est hydrogène, C¿1?-C¿6? alkyle, C¿1?-C¿6? perhaloalkyle, C¿3?-C¿10? cycloalkyle, hétérocycloalkyle de 3 à 10 segments, aryle ou hétéroaryle, ou R¿7? pris avec R¿8?, forment un hétérocycloalkyle de 3 à 7 segments; R¿9?-R¿12? sont indépendamment hydrogène, C¿1?-C¿4? alkyle, C¿1?-C¿4? perhaloalkyle, halogène, C¿1?-C¿4? alcoxy, ou cyano, ou R¿9? pris avec R¿10? ou R¿11? pris avec R¿12? peuvent former un C¿5?-C¿7? aryle; toutefois, l'un au moins des R¿9-12? ne doit pas être hydrogène; W est O, NR¿6?, ou est absent; Y est -(CO)- ou -(CO¿2?)-, ou est absent; Z est C¿1?-C¿4? alkyle, -CN, -CO¿2?R¿6?, COR¿6?, -CONR¿7?R¿8?, -OCOR¿6?, -NR¿6?COR¿7?, -OCONR¿6?, -OR¿6?, -SR¿6?, -SOR¿6?, -SO¿2?R¿6?, SR¿6?N(R¿7?R¿8?), -N(R¿7?R¿8?) ou phényle; G est aryle ou hétéroaryle bicyclique fusionné; enfin, X est une liaison, -NH, C¿1?-C¿6? alkyle, C¿1?-C¿6? alcényle, C¿1?-C¿6? alcoxy, C¿1?-C¿6? thioalkyle, C¿1?-C¿6? alkylamino, ou (CH)J; J est C¿1?-C¿6? alkyle, C¿3?-C¿7? cycloalkyle, phényle ou benzyle; et n est un entier de 1 à 6. Ces composés conviennent au traitement d'affections associées aux virus de l'herpès, y-compris le cytomégalovirus humain, aux herpèsvirus simplex, au virus d'Epstein-Barr, virus varicelle-zona, aux herpèsviruses-6 et -7 humains, à l'herpèsvirus de Kaposi.
Bloom Jonathan David
Curran Kevin Joseph
Digrandi Martin Joseph
Dushin Russell George
Lang Stanley Albert
American Home Products Corporation
Smart & Biggar
Wyeth
LandOfFree
Thiourea inhibitors of herpes viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiourea inhibitors of herpes viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiourea inhibitors of herpes viruses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1595188